Histocompatibility Testing
"Histocompatibility Testing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed)
| Descriptor ID |
D006650
|
| MeSH Number(s) |
E01.370.225.812.385 E05.200.812.385 E05.478.594.385
|
| Concept/Terms |
Histocompatibility Testing- Histocompatibility Testing
- Histocompatibility Testings
- Testing, Histocompatibility
- Testings, Histocompatibility
- Crossmatching, Tissue
- Crossmatchings, Tissue
- Tissue Crossmatching
- Tissue Crossmatchings
- Tissue Typing
- Tissue Typings
- Typing, Tissue
- Typings, Tissue
HLA Typing- HLA Typing
- HLA Typings
- Typing, HLA
- Typings, HLA
|
Below are MeSH descriptors whose meaning is more general than "Histocompatibility Testing".
Below are MeSH descriptors whose meaning is more specific than "Histocompatibility Testing".
This graph shows the total number of publications written about "Histocompatibility Testing" by people in this website by year, and whether "Histocompatibility Testing" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 4 | 6 |
| 1995 | 2 | 2 | 4 |
| 1996 | 0 | 3 | 3 |
| 1997 | 2 | 4 | 6 |
| 1998 | 2 | 4 | 6 |
| 1999 | 3 | 9 | 12 |
| 2000 | 2 | 3 | 5 |
| 2001 | 0 | 6 | 6 |
| 2002 | 1 | 2 | 3 |
| 2003 | 0 | 8 | 8 |
| 2004 | 1 | 10 | 11 |
| 2005 | 0 | 7 | 7 |
| 2006 | 2 | 2 | 4 |
| 2007 | 4 | 4 | 8 |
| 2008 | 1 | 2 | 3 |
| 2009 | 1 | 8 | 9 |
| 2010 | 2 | 6 | 8 |
| 2011 | 5 | 4 | 9 |
| 2012 | 1 | 9 | 10 |
| 2013 | 1 | 6 | 7 |
| 2014 | 3 | 6 | 9 |
| 2015 | 4 | 8 | 12 |
| 2016 | 1 | 6 | 7 |
| 2017 | 2 | 7 | 9 |
| 2018 | 5 | 3 | 8 |
| 2019 | 2 | 1 | 3 |
| 2020 | 0 | 4 | 4 |
| 2021 | 0 | 3 | 3 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 2 | 2 |
| 2024 | 3 | 6 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Histocompatibility Testing" by people in Profiles.
-
Interplay between donor age and HLA-DP matching in 10/10?HLA-matched unrelated donor HCT. Blood Adv. 2024 10 22; 8(20):5438-5449.
-
Haploidentical vs HLA-matched sibling donor HCT with PTCy prophylaxis: HLA factors and donor age considerations. Blood Adv. 2024 10 22; 8(20):5306-5314.
-
ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA Antibodies. Transplant Cell Ther. 2024 Dec; 30(12):1139-1154.
-
Haploidentical Versus Mismatched Unrelated Donor Hematopoietic Cell Transplantation: HLA Factors and Donor Age Considerations. Transplant Cell Ther. 2024 Sep; 30(9):909.e1-909.e11.
-
SOHO State of the Art Updates and Next Questions | Current Status and Future Directions of Donor Selection. Clin Lymphoma Myeloma Leuk. 2024 Dec; 24(12):821-826.
-
Combined effect of unrelated donor age and HLA peptide-binding motif match status on HCT outcomes. Blood Adv. 2024 05 14; 8(9):2235-2242.
-
Improved survival with younger HLA-matched unrelated donors versus older matched sibling donor HCT with PTCy-prophylaxis. Leukemia. 2024 Jun; 38(6):1432-1434.
-
HLA molecular mismatches and induced donor-specific tolerance in combined living donor kidney and hematopoietic stem cell transplantation. Front Immunol. 2024; 15:1377535.
-
Improving Unrelated Donor Equity: Assessing Mismatched Donor Opportunities with Real-World Data in a Minority-Predominant Cohort. Transplant Cell Ther. 2024 May; 30(5):544.e1-544.e8.
-
HLA mismatch is important for 20-year graft survival in kidney transplant patients. Transpl Immunol. 2023 10; 80:101861.